XASX
SHG
Market cap38mUSD
Oct 09, Last price
0.17AUD
1D
-2.94%
1Q
-21.43%
Jan 2017
-99.56%
IPO
-65.63%
Name
Singular Health Group Ltd
Chart & performance
P/E
—
P/S
37.46
EPS
—
Div yield, %
—
Shrs. gr., 5y
25.04%
Rev. gr., 5y
49.13%
Revenues
1m
+156.14%
Net income
-6m
L-0.56%
CFO
-5m
L+126.47%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.
Key people
Non-Executive Chairman of the Board · since 2021
Kyla Garic
Chief Financial Officer · since 2023
James Hill
Chief Operating Officer · since 2021
Denning Chong
Chief Executive Officer, Managing Director, Director · since 2023
Martina Mariano
Chief Commercial Officer · since 2024
Steven Wood
Joint Company Secretary · since 2023
Non-Executive Director · since 2021
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||